-
1by Sultan A.H.K.; Chakravarthi S.; Kabir M.S.; Shirin L.; Hardev Singh H.S.; Mazumder M.M.; Farzana Y.; Ying T.S.; Raman K.S.; Chia T.Y.; Noureen A.; Nazmul M.H.M.“… and chemotherapy for HER2-positive AGC in the United States; and Dostarlimab for previously treated MSI-H AGC…”
Published in South African Gastroenterology Review (2024)
Get full text
Article